title: Effect of zinc supplementation between 1 and 6 mo of life on growth and morbidity of Bangladeshi infants in urban slums.
abstract: BACKGROUND
  Evidence for an effect of zinc supplementation on growth and morbidity in very young infants in developing countries is scarce and inconsistent.
  
  
  OBJECTIVE
  We assessed the effect of zinc supplementation on growth and morbidity in poor Bangladeshi infants aged 4-24 wk.
  
  
  METHODS
  Infants from Dhaka slums were enrolled at 4 wk of age and randomly assigned to receive 5 mg elemental Zn/d (n = 152) or placebo (n = 149) until 24 wk of age. They were followed weekly for information on compliance and morbidity; anthropometric measurements were performed monthly. Serum zinc was assessed at baseline and at 24 wk of age.
  
  
  RESULTS
  At 24 wk of age, serum zinc concentrations were higher in the zinc than in the placebo group (13.3 +/- 3.8 and 10.7 +/- 2.9 micro mol/L, respectively; P < 0.001). Significantly greater weight gains were observed in the zinc than in the placebo group for 43 infants who were zinc deficient (< 9.18 micro mol/L) at baseline (3.15 +/- 0.77 and 2.66 +/- 0.80 kg, respectively; P < 0.04). In the other infants, no significant differences were observed in mean weight and length gains during the study period. Zinc-deficient infants showed a reduced risk of incidence of acute lower respiratory infection after zinc supplementation (relative risk: 0.30; 95% CI: 0.10, 0.92); among the non-zinc-deficient infants there were no significant differences between treatment groups.
  
  
  CONCLUSIONS
  Zinc-deficient Bangladeshi infants showed improvements in growth rate and a reduced incidence of acute lower respiratory infection after zinc supplementation. In infants with serum zinc concentrations > 9.18 micro mol/L, supplementation improved only biochemical zinc status.
authors.affiliation: International Center for Diarrhoeal Disease Research, Bangladesh (ICDDR,B): Centre for Health and Population Research, Dhaka, Bangladesh. saskia.osendarp@uniliver.com
authors.forename: Saskia J M
authors.initials: SJ
authors.lastname: Osendarp
authors.forename: Mathuram
authors.initials: M
authors.lastname: Santosham
authors.forename: Robert E
authors.initials: RE
authors.lastname: Black
authors.forename: M A
authors.initials: MA
authors.lastname: Wahed
authors.forename: Joop M A
authors.initials: JM
authors.lastname: van Raaij
authors.forename: George J
authors.initials: GJ
authors.lastname: Fuchs
mesh_terms: D000208:Acute Disease; D000375:Aging; D001459:Bangladesh / Q000453:epidemiology; D001827:Body Height; D001942:Breast Feeding; D002508:Cephalometry; D003906:Developing Countries; D003967:Diarrhea / Q000453:epidemiology; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D007223:Infant; D007225:Infant Food; D007231:Infant, Newborn; D008297:Male; D010349:Patient Compliance; D010919:Placebos; D011203:Poverty; D012141:Respiratory Tract Infections / Q000453:epidemiology*; D014505:Urban Population; D015430:Weight Gain; D015032:Zinc / Q000008:administration & dosage* / Q000097:blood / Q000172:deficiency
chemical_list: D010919:Placebos; D015032:Zinc